West Pharmaceutical Services (WST) Set to Announce Quarterly Earnings on Thursday

West Pharmaceutical Services (NYSE:WST) will post its quarterly earnings results before the market opens on Thursday, October 24th. Analysts expect West Pharmaceutical Services to post earnings of $1.51 per share for the quarter. West Pharmaceutical Services has set its FY 2024 guidance at 6.350-6.650 EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company had revenue of $702.10 million during the quarter, compared to analysts’ expectations of $729.36 million. During the same quarter last year, the firm posted $2.11 EPS. West Pharmaceutical Services’s revenue for the quarter was down 6.9% compared to the same quarter last year. On average, analysts expect West Pharmaceutical Services to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

West Pharmaceutical Services Trading Down 0.7 %

WST stock opened at $288.95 on Thursday. The firm’s fifty day simple moving average is $299.94 and its two-hundred day simple moving average is $326.36. The stock has a market capitalization of $20.96 billion, a price-to-earnings ratio of 41.10, a price-to-earnings-growth ratio of 10.53 and a beta of 1.01. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services has a twelve month low of $265.00 and a twelve month high of $413.70.

Insider Activity at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total value of $308,700.00. Following the transaction, the vice president now owns 1,478 shares of the company’s stock, valued at $443,400. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.53% of the stock is owned by company insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.